Taw qhia ntawm CAS: 201004-29-7|FMOC-LYS(ME3)-OH HCL
Supramolecular Gels: Fmoc-Lys(Fmoc)-OH yog siv los tsim cov supramolecular hydrogels, uas muaj cov ntawv thov hauv biomedical teb vim lawv cov khoom siv biocompatible thiab biodegradable. Cov gels no qhia txog kev siv tshuaj tua kab mob, thiab lawv cov txiaj ntsig tuaj yeem txhim kho nrog cov nyiaj sib tov.
Polypeptide Synthesis: Fmoc-Lys(Boc)-OH yog siv los tsim cov polypeptides, uas tuaj yeem muab txoj hauv kev tshiab rau kev tiv thaiv kab mob thiab kev kho mob. Cov txheej txheem synthesis aims txhim kho efficiency thiab tawm los.
Specification of CAS: 201004-29-7|FMOC-LYS(ME3)-OH HCL
|
Yam khoom |
SPECIFICATION |
|
Molecular Nyhav |
446.97 |
|
Molecular Formula |
C24H31ClN2O4 |
|
Daim ntawv |
Hmoov |
|
Solubility |
Soluble hauv Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, thiab lwm yam. |
Kev Tshawb Fawb Daim Ntawv Thov CAS: 201004-29-7|FMOC-LYS(ME3)-OH HCL
Organogelators: Fmoc thiab Boc mono-hloov cyclo (L-Lys-L-Lys)s ua haujlwm ua organogelators, tsim cov thermo-reversible organogels ruaj khov hauv ntau cov kuab tshuaj. Cov ntaub ntawv no nws tus kheej sib sau ua ke rau hauv nanofiber, nanoribbon, lossis nanotube network qauv, uas muaj peev xwm siv hauv nanotechnology (Zong li al., 2016).
Peptide Ligation: Azido-tiv thaiv Fmoc-Lys-OH yog synthesized thiab siv nyob rau hauv peptide ligation, ib tug txheej txheem tseem ceeb nyob rau hauv lub synthesis ntawm ntau yam biomolecules (Katayama li al., 2008).
Ultrasound-induced gelation: Fmoc-Lys(Fmoc)-OH thiab nws cov derivatives muaj peev xwm gellate ntau yam cawv thiab cov kuab tshuaj tsw qab nyob rau hauv sonication, displaying tsawg kawg nkaus gelation concentrations. Cov cuab yeej no yog qhov tseem ceeb rau kev txhim kho cov ntaub ntawv tshiab thiab kev xa tshuaj (Geng li al., 2017).
Lipidomics: Fmoc chloride yog siv rau hauv kev tshuaj xyuas ntawm ethanolamine glycerophospholipid (PE) thiab lysoPE molecular hom, txhim kho qhov rhiab heev thiab kev txheeb xyuas hauv huab hwm coj spectrometry, uas yog qhov tseem ceeb rau kev nkag siab txog cov lipidomes complex (Han li al., 2005).
Antimicrobial Peptides: Fmoc pawg yog siv rau hauv cov synthesis ntawm antimicrobial peptides, uas muaj peev xwm siv tau los kho cov kab mob (Liakopoulou-Kyriakides li al., 1997).
Insulin Analogs Synthesis: Fmoc-Lys(Pac)-OH yog siv rau hauv kev npaj cov tshuaj tshiab semisynthetic insulin analogs, ib qho kev nce qib tseem ceeb hauv kev kho mob ntshav qab zib (Žáková li al., 2007).
Cim npe nrov: cas:201004-29-7|fmoc-lys(me3)-oh hcl, China cas:201004-29-7|fmoc-lys(me3)-oh hcl manufacturers, hoobkas
